Ventas, IncNYSE: VTR
Real Estate · Health Care REITs
$84.67
-3.78%
Vol: 114K
Research Digest
Monday, June 15, 2026
No significant overnight updates
No material news in the last 48 hours.
Previous Market Intelligence
13 daysJun 14No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 21Ventas expands ATM equity program to $3B; analyst targets raisedPositive▶
Ventas filed Amendment No. 3 to its ATM Sales Agreement on May 15, 2026, increasing aggregate gross sales price to $3.0 billion. 2026 Annual Meeting held May 13 with all 12 director nominees elected and KPMG ratified. Executive Peter Bulgarelli retired May 1 with separation agreement. Multiple analysts raised price targets: Goldman Sachs to $110 (from $100) on May 15, Jefferies to $100 (from $97) on May 12.
May 20Ventas amended its ATM equity program to $3B on May 15 and saw a wave of analyst price target hikes (Goldman to $110, Jefferies to $100) after the stock hit an all-time high of $91.06.Positive▶
Ventas filed Amendment No. 3 to its ATM sales agreement on May 15, expanding the at-the-market equity program capacity to $3.0B in common stock issuance, signaling intent to fund continued senior housing growth via equity. The 2026 Annual Meeting on May 13 saw all 12 directors elected and KPMG ratified with strong support. Multiple analyst price target hikes followed Q1 strength: Goldman Sachs raised to $110 from $100 (May 15), Jefferies to $100 from $97 (May 12), JPMorgan to $94 from $93 (May 11), and KeyBanc to $95 from $90 (May 7). The stock hit an all-time high of $91.06 on May 15 after Q1 2026 normalized FFO of $0.94 (+9% YoY), a dividend hike to $0.52/share, and raised full-year guidance ($3.78-$3.88). Risks: increased equity issuance could pressure shares near-term, and rising rates remain a headwind for REITs at peak valuations.
May 19Ventas amended ATM equity program to $3B capacity on May 15 and reached all-time high $91.06 on robust Q1 senior housing performance.Positive▶
On May 15, 2026, Ventas amended its ATM sales agreement to $3.0B aggregate capacity to support senior housing growth. Q1 2026 normalized FFO rose 9% to $0.94, with dividend raised to $0.52 quarterly ($2.08 annualized) from $0.48. Stock reached all-time high $91.06 on May 15. 2026 Annual Meeting on May 13 saw all 12 directors elected and KPMG ratified. Jefferies raised PT to $100 from $97 (May 12); JPMorgan to $94 from $93 (May 11). Bear case: $3B equity program could dilute if deployed aggressively; senior housing supply could pressure rents.
May 18Ventas amended its ATM equity program on May 15 to increase aggregate sales capacity to $3.0 billion, signaling intent to raise meaningful equity capital.Positive▶
Ventas entered Amendment No. 3 to its ATM Sales Agreement on May 15, 2026, increasing the aggregate gross sales price of common stock available for issuance under the program to $3,000,000,000. The expansion gives the REIT greater flexibility to fund senior housing investments amid strong Q1 momentum (22% revenue growth, raised FFO guidance to $3.82-$3.89). At the 2026 Annual Meeting held May 13, all 12 director nominees were elected and executive compensation received advisory approval. The company also disclosed a separation agreement with executive Peter J. Bulgarelli tied to his May 1 retirement. Multiple analysts including Jefferies have raised price targets into the $93-$100 range. Sentiment is moderately positive on senior housing demand strength.
May 15Ventas declares $0.52 quarterly dividend; stock hits all-time high on senior housing strength and raised FY guidancePositive▶
Ventas declared a $0.52 quarterly common dividend on May 13, payable July 16 to holders of record June 30. The stock hit an all-time high of $87.24 supported by Q1 2026 results showing revenue up 22% YoY, EPS of $0.94 (beating $0.91 estimate), SHOP NOI up 15%+, and a raised FY FFO guidance to $3.82-$3.89 per share. Senior housing demand and occupancy gains continue to fuel positive analyst sentiment. KeyBanc raised PT to $95 (Overweight) and Jefferies raised to $100 (Buy). Risk: shares already near consensus average PT of $90.46, limiting near-term upside.
May 14Ventas declares $0.52 quarterly dividend, hits all-time high near $87 after Q1 revenue grew 22% YoY and net income jumped 83%Positive▶
Ventas declared a quarterly dividend of $0.52 per common share on May 13, 2026, payable July 16 to stockholders of record June 30. The REIT beat Q1 2026 estimates with EPS of $0.94 (vs $0.91 consensus) and reported 22% YoY revenue growth and an 83% rise in net income, driven by strong senior housing fundamentals. Management raised full-year FFO guidance to $3.82-$3.89 per share and emphasized a strategic shift toward regional operators in senior housing. The stock has reached an all-time high near $87.42, up 33.66% over the past year and 6.25% week-over-week. According to 13 analysts, the consensus rating is Buy with a 12-month price target of $90.46. Multiple analysts raised their targets following the Q1 results.
May 13Ventas raises dividend, beats Q1 estimates, and lifts senior housing investment target to $3 billionPositive▶
Ventas reported strong Q1 2026 results that beat expectations, with revenue up 22% YoY to $1.66 billion and normalized FFO per share up 9% to $0.94. The healthcare REIT raised its quarterly dividend to $0.52/share ($2.08 annualized) from $0.48 and lifted full-year FFO guidance to $3.82-$3.89 per share. Investment guidance for 2026 was raised to $3 billion focused on senior housing (up from $2.5 billion), with $1.7 billion already completed YTD through April. The 15% NOI growth in the senior housing operating portfolio (SHOP) drove performance. KeyBanc raised its price target to $95 from $90 with an Overweight rating, and consensus target is $93.56. The stock hit an all-time high of $87.20 and shares rose approximately 1.9% on the earnings release date.
May 12Ventas hits all-time high near $87 as KeyBanc raises PT to $95 after Q1 26 revenue jumps 22% and FFO guidance liftedPositive▶
Ventas Q1 2026 revenue rose 22% YoY to $1.66B and normalized FFO/share grew 9% to $0.94, driven by strength in its SHOP (senior housing) portfolio. Management raised FY26 FFO guidance to $3.82-$3.89. Analyst PT increases: KeyBanc to $95 from $90 (May 7), BMO to $100 from $93 (May 4), RBC to $98 from $91 (May 4). Stock hit all-time high of $87.20 on May 8. Swedbank AB increased its VTR stake by 7.8% in Q4. YTD return ~13.82% with 30-day return of 7.33%.
May 11No significant overnight updatesNeutral▶
No material news in the last 48 hours.
May 8Ventas Q1 beats with 22% revenue growth and 9% FFO increase; raises full-year investment guidance.Positive▶
Ventas reported strong Q1 2026 with revenue up 22% year-over-year to $1.66 billion and normalized FFO up 9% to $0.94 per share, beating estimates of $0.91. Senior housing segment posted double-digit growth with SHOP NOI up 15%+ and occupancy gains. Company closed over $1.7 billion in acquisitions year-to-date with record liquidity and raised investment guidance to $3 billion. RBC Capital maintained Buy with $98.00 target. Analyst consensus rating is Strong Buy with average target $93.87, implying 6.65% upside.
May 7Ventas beats Q1 EPS by 3.3% at $0.94; FFO/share up 9%, revenues surge 22%; company raises FY26 guidance to $3.82-$3.89 per share.Positive▶
Ventas delivered strong Q1 2026 results with EPS of $0.94 beating $0.91 estimate, normalized FFO per share up 9%, and revenues rising 22%. Senior housing NOI jumped 15%+, supported by occupancy gains. Company raised FY26 guidance to $3.82-$3.89 per share FFO. Over $1.7B in acquisitions closed YTD; liquidity at record levels; investment guidance increased to $3B. Company targets 8% FFO growth, 15% SHOP NOI growth, $2.5B senior housing investments in 2026. With 850+ senior housing communities, company positioned to capitalize on aging population and limited new supply. Analyst consensus: Buy with average PT of $87.62.
May 6Ventas reports 9% FFO growth; raises 2026 guidance on strong senior housing demandPositive▶
Ventas reported Q1 2026 results with normalized FFO per share up 9% and revenues up 22%. Senior housing properties showed exceptional momentum with SHOP NOI up 15%+ and occupancy gains, leading the company to raise full-year FFO guidance to $3.82-$3.89 per share. The REIT closed over $1.7B in acquisitions year-to-date and increased 2026 investment guidance to $3B. Strong aging population demographics and limited new supply support the favorable outlook. VTR stock is up 33.7% over 12 months and trades at $88.37 with "Buy" consensus from 13 analysts.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| WELLWELLTOWER | $215.00 | -0.47% | +1.6% | 64.9x | 0.82 | $152.5B |
| VTRVENTAS | $84.67 | -3.78% | -0.2% | 103.9x | 0.76 | $42.8B |
| DOCHEALTHPEAK | $20.69 | +5.35% | +0.8% | 145.5x | 0.98 | $13.5B |
| PLDPROLOGIS | $149.50 | +3.37% | +1.6% | 42.6x | 1.35 | $134.8B |
| EQIXEQUINIX | $1,076.27 | -0.20% | +1.5% | 56.1x | 1.00 | $106.4B |
| AMTAMERICAN | $187.06 | +1.78% | +3.7% | 26.6x | 0.90 | $85.6B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price between 50d and 200d. Testing 50d support.